D-0010-2023 Class II

Recalled by Ingenus Pharmaceuticals Llc — Orlando, FL

FDA drug recall D-0010-2023 was initiated by Ingenus Pharmaceuticals Llc on Sep 30, 2022 and is designated Class II. Reason for recall: Out of specification for related substances (impurities). Affected quantity: 6176 bottles.

Recall details

Product Type
Drugs
Report Date
Oct 26, 2022
Initiation Date
Sep 30, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
6176 bottles

Product description

Flunisolide Nasal Solution, USP 0.025%, 25 mL bottles, Rx only, Manufactured for: Ingenus Pharmaceuticals, LLC Orlando, FL 32839-6408; NDC 50742-317-25 UPC 3 50742 31725 7

Reason for recall

Out of specification for related substances (impurities).

Distribution pattern

Nationwide within the United States

Code information

Lot #: 22E040 Exp. 07/2023; 22F038 Exp. 08/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0010-2023
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0010-2023. Report a data issue: hello@regdatalab.com.